Phibro Animal Health (PAHC) Receivables (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Receivables of $221.5 million for Q1 2026, up 12.16% year-over-year from $197.5 million in Q1 2025, and up 2.63% quarter-over-quarter from $215.9 million in Q4 2025.
Phibro Animal Health (PAHC) Receivables (2013 - 2026) Analysis & Trends
Phibro Animal Health's Receivables history runs 14 years deep, the most recent figure standing at $221.5 million for Q1 2026.
- In Q1 2026, Receivables rose 12.16% year-over-year to $221.5 million; the TTM figure through Mar 2026 stood at $221.5 million (up 12.16% YoY), while the FY2025 annual figure was $228.0 million, up 34.54% from the prior year.
- Receivables for Q1 2026 stood at $221.5 million, up from $215.9 million in the prior quarter.
- The five-year high for Receivables was $228.0 million in Q2 2025, with the low at $142.7 million in Q3 2022.
- The 5-year median for Receivables is $165.1 million (2023), against an average of $176.6 million.
- The sharpest annual moves came in 2023 and 2025: Receivables dropped 2.93% in 2023, then soared 35.53% in 2025.
- Phibro Animal Health's Receivables stood at $151.8 million in 2022, then declined by 0.79% to $150.6 million in 2023, then grew by 27.33% to $191.8 million in 2024, then climbed by 12.56% to $215.9 million in 2025, then gained by 2.63% to $221.5 million in 2026.
- Business Quant data shows PAHC's Receivables at $221.5 million in Q1 2026, $215.9 million in Q4 2025, and $217.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 221.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221.55 Mn |
| Dec 31, 2025 | 215.87 Mn |
| Sep 30, 2025 | 217.90 Mn |
| Jun 30, 2025 | 227.98 Mn |
| Mar 31, 2025 | 197.52 Mn |
| Dec 31, 2024 | 191.79 Mn |
| Sep 30, 2024 | 160.78 Mn |
| Jun 30, 2024 | 169.45 Mn |
| Mar 31, 2024 | 161.09 Mn |
| Dec 31, 2023 | 150.63 Mn |
| Sep 30, 2023 | 149.23 Mn |
| Jun 30, 2023 | 165.07 Mn |
| Mar 31, 2023 | 152.74 Mn |
| Dec 31, 2022 | 151.83 Mn |
| Sep 30, 2022 | 142.73 Mn |
| Jun 30, 2022 | 170.05 Mn |
| Mar 31, 2022 | 156.56 Mn |
| Dec 31, 2021 | 142.50 Mn |
| Sep 30, 2021 | 140.64 Mn |
| Jun 30, 2021 | 150.66 Mn |